Table 1. Characteristics of the journals included in the study.
Characteristics | Number of journals n = 399 (%) |
Editorial office site | |
○USA | 220 (55.1) |
○Europe | 132 (33.1) |
○Europe and USA | 23 (5.8) |
○Canada | 10 (2.5) |
○Other countries | 14 (3.5) |
Type of contents | |
○Clinical | 123 (30.8) |
○Basic | 162 (40.6) |
○Clinical and basic | 114 (28.6) |
Publisher | |
○Elsevier | 90 (22.6) |
○Wiley-Blackwell | 59 (14.8) |
○Springer | 29 (7.3) |
○Nature | 28 (7.0) |
○Lippincott WW | 23 (5.8) |
○Oxford Journals | 21 (5.3) |
○Mary Ann Liebert | 7 (1.8) |
○Other | 142 (35.6) |
Endorsement of policy-producing body guidelines | |
○ICMJE | 159 (39.8) |
○COPE | 157 (39.3) |
○WAME | 44 (11.0) |
○ORI | 32 (8.0) |
○CSE | 6 (1.5) |
○Other bodies * | 21 (5.3) |
Source of misconduct policies | |
○Journal | 132 (33.1) |
○Publisher | 143 (35.8) |
○Editors’ associations/ORI/professional societies | 124 (31.1) |
Misconduct policies | |
○Mention of misconduct | 279 (69.9) |
○Definition of misconduct | 140 (35.1) |
○Falsification | 113 (28.3) |
○Fabrication | 104 (26.1) |
○Plagiarism | 224 (56.1) |
○Duplication | 242 (60.7) |
○Image manipulation | 69 (17.3) |
○Other forms of misconduct † | 154 (38.6) |
Plagiarism-checking service | 112 (28.1) |
Procedures for responding to | 179 (44.9) |
○Retraction | 123 (30.8) |
○Expression of concern | 65 (16.3) |
○Other procedures ‡ | 130 (32.6) |
Mainly professional societies such as British Cardiovascular Society, American Diabetes Association and The Endocrine Society.
Examples include, among others, ‘suppression of undesirable results’, ‘multiple publication’ and ‘misinterpretation of results’.
Examples include, among others, ‘publish complete errata’, ‘letter of explanation’ and ‘letter of reprimand’.